ArticleHarm reduction journal2025

Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada.

Samara Mayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.